前往化源商城

Biopharmaceutics & Drug Disposition 1985-01-01

Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.

R Zaman, D B Jack, M R Wilkins, M J Kendall

文献索引:Biopharm. Drug Dispos. 6(2) , 131-7, (1985)

全文:HTML全文

摘要

The pharmacokinetics of acebutolol and its major metabolite, diacetolol, following a single 400 mg oral dose, were investigated in patients with liver disease. No significant differences were found in any of the parameters measured.

相关化合物

结构式 名称/CAS号 全部文献
N-(3-乙酰基-4-(2-羟基-3-(异丙基氨基)丙氧基)苯基)乙酰胺 结构式 N-(3-乙酰基-4-(2-羟基-3-(异丙基氨基)丙氧基)苯基)乙酰胺
CAS:22568-64-5